News

The EMBO Journal5h
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation
Microglia activation is the brain's major immune response to amyloid plaques in Alzheimer's disease (AD). Both cerebrospinal fluid (CSF) levels of soluble TREM2 (sTREM2), a biomarker of microglia ...
FDA Expands Indications for Neuraceq®, an Amyloid PET Imaging Agent, to Enhance Diagnosis and Care of Patients with Alzheimer's Disease
Life Molecular Imaging, Ltd. (LMI) announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Neuraceq® (florbetaben F18 injection), expanding its indication for ...
MPR9h
FDA Approves Updated Label for Amyloid PET Imaging Agent Amyvid
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
Medical Dialogues13h
Study: Iron plays a major role in down syndrome-associated Alzheimer’s disease
Scientists at the USC Leonard Davis School of Gerontology have discovered a key connection between high levels of iron in the ...
ScienceAlert16h
There's a Critical Thing We Can All Do to Hold Alzheimer's Symptoms at Bay
Deep sleep could forestall the declines in brain health that can eventually lead to Alzheimer's disease, the most common form ...
Physician's Weekly22h
Late-Life Mood Disorders May Indicate Predisposition to Dementia
Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a ...
Brain fog, bad mood and memory woes? It could just be your sleep
Prioritizing sleep is crucial for cognitive function, memory consolidation, and toxin removal. Insufficient sleep, common in today's fast-paced world, ...